Uber for Healthcare in Latinamerica
Public company, workplace, funding, and market signals
Chilean healthtech founded in 2020 (launched in 2021) that helps patients and employers book at-home lab tests, vaccinations, and telemedicine, with a strong reimbursement layer and a profitability-focused reset since 2025.
Primary product
At-home medical diagnostics and telemedicine platform
Founded
2020
Headquarters
Las Condes, Santiago Metropolitan Region, Chile
Team size
40-50
Work style
Hybrid
Industry
Technology, Information and Internet
Sub-industry
Healthtech / digital health marketplace
Offices
Business model
Stage
Series A / Series A-II
Total raised
$20.7M
Latest round
Series A - II · Nov 2025
Latest amount
$750K
Leadership
Co-Founder & CTO
Co-Founder & CSO
Chief Financial Officer
Public hiring and company posts describe a meritocratic, transparent, results-oriented culture with continuous improvement, disciplined execution, and a strong focus on patient impact.
Work style
Hybrid
Compensation
Public job posts emphasize competitive compensation; clinical roles are often freelance/boleta de honorarios and paid per visit or appointment, while some openings ask candidates to state salary expectations.
Benefits
Pricing
Direct pay per service, with reimbursable and insurance-covered flows for eligible patients; telemedicine starts at CLP 25,000; corporate services are sold via purchase order / enterprise agreements.
Differentiators
Technology
Customers
Competitors
Estimated revenue
Conflicting public estimates: roughly $1M/year on company-profile sources to about $14.9M ARR on GetLatka; treat as directional rather than precise.
Estimated monthly visits
71.7K
Traffic estimate as of Jul 2026
Leadership reset and restructuring: Mariano Werner became CEO, Ian Lee stepped back from day-to-day management, and reports said Juan Pablo Zepeda and Alberto Albagli left operational roles; coverage also described headcount reductions and closures of some cities / business units.
SourceDown round / cap-table reset: Examedi raised $750K led by Platanus, General Catalyst exited, and the company shifted toward a lower-growth, profitability-first model with a roughly $17M valuation.
SourceLatamList · Nov 2025
Reported the $750K round led by Platanus, General Catalyst's exit, and Examedi's pivot toward profitable growth in Chile and Mexico.
Diario Financiero / DF MAS · Feb 2025
Detailed the leadership overhaul, founder departures from day-to-day operations, and workforce / operating-unit reductions.
Fast Company · Mar 2024
Profiled Examedi's expanded service set, including 24/7 doctor access, assisted telemedicine, and the new app.
Examedi blog · Oct 2023
Official launch note for the new app and broader product expansion beyond core at-home testing.
Examedi blog · Jun 2022
Official announcement of the Series A led by General Catalyst and participation from named angel investors.
0 jobs at Examedi
Check back later for new openings